Why Epic Is Launching a Prescription Price Comparison Tool
Epic will launch a tool in summer 2027 to help patients compare prescription cash prices and insurance costs across pharmacies.
Epic will launch a tool in summer 2027 to help patients compare prescription cash prices and insurance costs across pharmacies.
Rosarium Health partnered with Anthem Medi-Cal to provide home safety modifications for eligible members.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
HealthTap launched a virtual care program to support sleep equipment suppliers and patients using PAP therapy.
Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah Grey Ventures, SemperVirens, Brock Recovery Group and Pave Health Ventures.
The Series A round was led by Oak HC/FT, with participation from Norwest, .406 Ventures, Constellation Ventures, Y Combinator, Rock Health Capital and MemorialCare Innovation Fund.
Trilliant Health’s report identifies six trends highlighting how misaligned incentives are contributing to rising costs, poor health outcomes, workforce shortages and other systemic problems in U.S. healthcare.
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
The FTC sent warning letters to 24 major healthcare organizations over concerns about inadequate price transparency.
The Trump administration is issuing one-time $90 payments to more than 20 million Medicare beneficiaries to help cover Part B premiums, though the payments may do little to offset rising healthcare costs.
The Trump administration’s ACA fraud crackdown will remove 760,000 people from Marketplace coverage, drawing criticism from healthcare experts and advocates.
The Series A round was led by Canvas Ventures, with participation from Blank Space Ventures, StoryHouse Ventures and HMC INQ.
The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in 2024.
In this episode, we’re joined by Claire Love, deals strategy principal at PwC. We discuss PwC’s recent report showing the opportunities in the fertility and reproductive health market.
Health tech companies made several major funding announcements in September. Here is a list of some of the biggest funding rounds.
Tiny Health's Series B round was led by B Capital, with participation from Spero Ventures, The Venture City, Overwater Ventures, Black Opal Ventures, Denver Ventures, Pave Health Ventures, Alumni Ventures, Gaingels and Pari Passu Ventures.
The Association for Direct Care launched a coalition focused on expanding direct contracting to lower healthcare costs.